Inovio Pharmaceuticals’ stock has climbed higher and higher over the past month since it said it was working on a speedy COVID-19 vaccine.

Pfizer and BioNTech have begun dosing participants in a U.S. clinical trial of their COVID-19 vaccine candidates. The dose-escalation stage of the trial will enroll up to 360 subjects, initially out of sites in New York and Maryland.

The FDA has delayed its decision on whether to approve Bristol Myers Squibb’s CAR-T cell therapy by three months. Bristol Myers attributed the delay to its submission of additional information upon the request of the FDA.

Moderna is finalizing the protocol for a phase 3 trial of its COVID-19 vaccine with a view to starting the study early in the summer. The establishment of the timeline, which follows FDA clearance to run a phase 2 trial, puts Moderna on track to win approval for its mRNA vaccine mRNA-1273 next year.

Johnson & Johnson taps Khan for chief data role; Icon poaches AstraZeneca vet Buck as CMO; Intellia signs on Lebwohl as CMO.

The results provide priceless information on ancestry and predispositions to various illnesses.

Scientists work tirelessly to find a coronavirus vaccine. But there are some questions to answer: How soon a viable vaccine would be developed? Would billions of people worldwide be able to to get it?

Among those rallying against state shutdown orders are anti-vaccination activists. They see these protests as a way to form political alliances that promote their movement.

The idea that old people are worth something because they contribute significantly to society puts us on a slippery slope.

Nursing facilities account for a large percentage of COVID-19 deaths. Better protection and testing can change that.

California reopening: On Abbot Kinney Boulevard in Venice, the normally bustling shopping district that has been largely vacant amid the coronavirus, there were signs of life Friday as some retailers opened for curbside service.

Older people who are more at risk of dying from COVID-19 contribute immeasurably to society, but they should not have to prove their worth.

Experts caution that even promising early results don’t guarantee that vaccines will be widely available anytime soon.

"Kids have moved on" to other nicotine vapes that will remain on the market.

The world's largest manufacturer says there's not enough capacity to quickly ramp up production to those levels.

A total of 10529 vacancies have been notified. Job Aspirants can go through the list of Government Jobs in this article.

Charles Lin will take on his leading role at CLSA, the HK-based broker Citic Securities acquired in 2013.

The post China’s Citic Securities hires Vanguard ex-Asia boss for global drive appeared first on DealStreetAsia.

The US-based venture capital firm routed the investment through its $60 million fund.

The post Mantra Capital makes maiden India investment in wellness startup SARVA appeared first on DealStreetAsia.

The company said the latest round was led by existing investor Sequoia Capital.

The post Fintech startup Robinhood raises fresh funds at $8.3b valuation appeared first on DealStreetAsia.

Ninja Van becomes one of the few startups to score new funding since Covid-19 chilled deal activity.

The post Singapore’s Ninja Van raises $279m after pandemic drives e-commerce surge appeared first on DealStreetAsia.

The Series D+ round was led by state-owned China Internet Investment Fund.

The post China’s ASR Microelectronics snags $119m at over $1.6b valuation appeared first on DealStreetAsia.

The financing will help Varthana reach more schools by meeting its need for longer-term capital.

The post Indian financier Varthana secures $15m debt financing from DFC appeared first on DealStreetAsia.

The financing was led by state-owned China Life Insurance Group’s healthcare fund. 

The post Chinese biotech firm Vazyme snags $78m in Series C round appeared first on DealStreetAsia.